22nd Century Group Inc
Change company Symbol lookup
Select an option...
XXII 22nd Century Group Inc
NTLA Intellia Therapeutics Inc
OLO Olo Inc
FTII Futuretech II Acquisition Corp
CTLP Cantaloupe Inc
ACQRU Independence Holdings Corp
ARHS Arhaus Inc
PARA Paramount Global
TD Toronto-Dominion Bank
GL Globe Life Inc
Go

Consumer Staples : Tobacco | Small Cap Growth
Company profile

22nd Century Group, Inc. is an agricultural biotechnology and intellectual property company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. In tobacco, hemp/cannabis, and hop plants, it uses various plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new plants with optimized alkaloid and flavonoid profiles, as well as improved yields and valuable agronomic traits. It has developed very low nicotine content (VLNC) tobacco and cigarettes, which contain 95% less nicotine than conventional tobacco and cigarettes. Its reduced nicotine cigarettes include VLN King and VLN Menthol King. In hemp, the Company is developing hemp varieties with increased levels of certain cannabinoids and other desirable agronomic traits. The Company has an interest in RX Pharmatech Ltd (RXP).

Postmarket

Last Trade
Delayed
$1.09
-0.01 (-0.91%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$1.10
Day's Change
0.04 (3.77%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
1.10
Day's Low
1.03
Volume
(Average)
Volume:
1,337,066

10-day average volume:
1,225,373
1,337,066

Display:

Providers:

UpdateCancel
6 providers
January 24, 2023
January 23, 2023
January 19, 2023
Grabar Law Office Investigates Claims on Behalf of Shareholders of 22nd Century Group, Inc. (XXII) as Securities Fraud Class Action Survives Motion to Dismiss

Philadelphia, Pennsylvania--(Newsfile Corp. - January 19, 2023) - A securities fraud class action alleging wrongdoing committed by certain of 22nd Century Group, Inc' Officers and Directors has survived a motion to dismiss the complaint. (Newsfile)

January 18, 2023
22nd Century Group (XXII) Announces U.S. Distribution Partnerships with Core-Mark and Eby-Brown

Two of the Largest U.S. Convenience Store Distributors Will Support VLN® Rollout into New States and Regions Expects Multiple Retail Chain Customers of Core-Mark and Eby-Brown to Carry 22nd Century's VLN® Cigarettes (Newsfile)

January 17, 2023
FDA's Proposed Menthol Ban Advances to Final Rule Status, Greatly Benefits 22nd Century (XXII) by Affirming the Need for VLN(R) Menthol King as a Critical Off-Ramp for Adult Menthol Smokers

Proposed Menthol Ban Could Leave 22nd Century's VLN® Menthol King as the Only Menthol Cigarette in the $26 Billion U.S. Menthol Market FDA to Advance Reduced Nicotine Content Standards for All Combustible Cigarettes in Q4 2023 (Newsfile)

January 10, 2023
Grabar Law Office Investigates Claims on Behalf of Shareholders of 22nd Century Group, Inc. (XXII) As Securities Fraud Class Action Survives Motion to Dismiss

Philadelphia, Pennsylvania--(Newsfile Corp. - January 10, 2023) - A securities fraud class action alleging wrongdoing committed by certain of 22nd Century Group, Inc's (NASDAQ: XXII) Officers and Directors has survived a motion to dismiss the...(Newsfile)

December 16, 2022
In a New Audio Interview, Toni Loudenbeck of Traders News Source Interviews John Miller President, 22nd Century Group Inc.

NEW YORK, NY / ACCESSWIRE / December 16, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with 22nd Century...(Accesswire)

December 13, 2022
22nd Century Group (XXII) Comments on the Advancement of New Zealand's National Reduced Nicotine Content Law

Buffalo, New York--(Newsfile Corp. - December 13, 2022) -  22nd Century Group, Inc. (NASDAQ: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant...(Newsfile)

December 08, 2022
22nd Century Group Provides Update on Grass Valley Facility

Buffalo, New York--(Newsfile Corp. - December 8, 2022) - GVB Biopharma, a 22nd Century Group company (NASDAQ: XXII), today provided updates on its operational recovery progress and customer shipments following a fire that occurred at its distillate...(Newsfile)

November 21, 2022
22nd Century Group Provides Update on Incident at Grass Valley Facility

Buffalo, New York--(Newsfile Corp. - November 21, 2022) - GVB Biopharma, a 22nd Century Group company (NASDAQ: XXII), today announced that a fire occurred at its GVB Biopharma distillate and isolate manufacturing facility located in Grass Valley...(Newsfile)

November 16, 2022
November 15, 2022
November 14, 2022
November 08, 2022
November 07, 2022

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.